Maria Fabrizo for STAT

As male birth control gets closer to reality, men are lining up for clinical trials

Men are signing up for clinical trials of new male birth control. Experts cite the Dobbs decision and desire to share burden of contraception

By Annalisa Merelli

Do mornings make cancer immunotherapy more effective? Study: Maybe

A curious phenomenon seen by oncologists, that morning patients do better than those receiving afternoon infusions, gains credence in a clinical trial.

By Angus Chen

To fix ‘spiritual malaise’ behind addiction, Kennedy announces efforts on homelessness and recovery 

Trump administration details a new addiction initiative led by HHS Secretary Kennedy emphasizing faith-based groups, tough love and recovery.

By Lev Facher

Illustration: Camille MacMillin/STAT; Photos: Adobe

STAT+ | Why Bristol Myers Squibb believes a decades-old drug can treat Alzheimer’s 

BMS faces a $20 billion annual revenue loss as its biggest drugs lose patent protection. It's counting heavily on an old drug's new use against Alzheimer's.

By Damian Garde

STAT+ | Federal judge dismisses lawsuit against academic publishers over unpaid peer review

Researchers who argued unpaid peer review violates antitrust law lost their case, as a judge ruled their claims fell short under the Sherman Act.

By Jonathan Wosen

Opinion: How much should psychedelics researchers disclose about their personal use?

Many psychedelics researchers have personal experience with the drugs, creating some ethical dilemmas.

By Ian Reardon

Erin Hooley/AP

Opinion: The EPA just erased a century of public health progress

By dropping lives saved from air pollution rules, the EPA breaks with a long tradition of valuing health over industry costs.

By Michelle A. Williams

STAT+ | Sanofi is reprimanded by a U.K. trade group for misleading claims about a Pfizer vaccine

The spat erupted a few months after the U.K. government chose Pfizer to supply its RSV shot to older adults and pregnant mothers.

By Ed Silverman